Bringing AI into professional drug safety monitoring and Patient Support Programs (PSPs)
AI-translated from the Chinese original · editorially reviewed
Patient Support Programs are an important development in healthcare, and combined with advances in artificial intelligence (AI), they are opening new possibilities. AI enriches patient support services with personalized recommendations, education, and financial management. In drug safety monitoring, AI identifies adverse events early and predicts drug interactions, strengthening patient safety.
Patient Support Programs and the rise of AI
The Patient Support Program (PSP) is a significant recent development in healthcare, designed to provide patients with comprehensive care and support services. As medical technology keeps evolving, AI (artificial intelligence) is emerging to bring unprecedented opportunities to PSP management and drug safety monitoring.
AI has already achieved major breakthroughs in medicine. The technology can not only process vast volumes of medical data but also analyze complex correlations, helping healthcare professionals make better-informed decisions. In PSPs and drug safety monitoring alike, AI will play a major role in advancing PSP services.
More diverse forms of support
Traditional PSPs focus mainly on patients' basic needs, including medication management and disease education. With the introduction of AI, the scope of patient support can expand into more diverse, personalized services — customized medical recommendations, patient health education, health status tracking, and financial management — to meet the needs of different patients.
The role of AI in professional drug safety monitoring
Drug safety monitoring is key to protecting patients from adverse events and drug interactions. Going forward, AI applications will bring professional-grade assistance to this field.
•Early detection of adverse events:
AI can analyze large volumes of patient data to rapidly identify potential adverse events. It can detect rare adverse event patterns and provide early alerts, helping PSP managers intervene in time.
•Predicting drug interactions:
AI algorithms can predict possible interactions between different drugs, helping physicians and pharmacists avoid potentially dangerous combinations and improving prescription safety — a supporting tool for medical professionals.
•Strengthening patient safety:
AI also plays a role in monitoring patients' health status. By analyzing physiological indicators and medical record data, it can provide personalized treatment recommendations, safeguarding patients' safety and wellbeing.
Personalized medication management
AI can improve not only drug safety monitoring but also deliver more personalized medication management — adjusting doses and treatment plans to each patient's specific condition and needs to ensure the best therapeutic outcome while reducing unnecessary risk.
The rise of AI is revolutionizing Patient Support Programs (PSPs) and drug safety monitoring, offering a wider range of support options while reinforcing professional drug safety surveillance to ensure patients receive the best possible care. As AI technology keeps advancing, we can expect patient support services to become ever smarter and more personalized, delivering a better quality of life for every patient. PATIENTSFORCE's Patient Support Program operations have recently adopted an AI-assisted system to boost the efficiency of patient service and care management, along with an automated voice system that delivers convenient medication adherence reminders — moving medication care management steadily toward precision health services.
Sean Chang, General Manager, Media-WIND Health Group (MWHG)